在体外人类离子通道测试中,可以预测药物诱导的发作
Jennifer D Cohen1, Dahea You1, Ashok K Sharma1
1Drug Safety Research & Evaluation, Takeda Development Center Americas, Inc, San Diego, CA 92121-1964, United States.
概括
这项研究表明,评估多个离子通道标,特别是Cav2.1,可以改善药物诱导的预测. 扩大体外试验有助于在药物发现中早期识别发作风险.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 发作代表了FDA对神经毒性的关键黑警告.
- 了解诱导发作的非标机制对于临床前风险识别至关重要.
研究的目的:
- 为了评估发作诱导活动的11个离子通道点的体外小组.
- 评估这些目标对临床前和已批准药物的预测能力.
主要方法:
- 自动化电生理学被用来测试34种临床前化合物和10种经批准的药物,在9个研究和2个标准离子通道目标上进行了测试.
- Cav2.1被确定为一个关键目标,随后对另外35种已批准的药物进行了测试.
主要成果:
- 卡维2.1显示出最高的命中频率 (20个EC30/IC30≤30μM的化合物).
- 对于临床前化合物 (52%的灵敏度,78%的特异性) 和已批准的药物 (48-54%的灵敏度,71-78%的特异性),Cav2.1试验显示了适度的预测价值.
- 一个集成的11个目标小组在预测临床前化合物诱导的方面实现了68%的灵敏度和56%的特异性.
结论:
- 扩大离子通道目标的体外面板可以提高对发作潜力的预测.
- 这种方法可以通过更早地识别发作风险,减少早期药物发现中的化合物消耗.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
144
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
144
Patch Clamp
5.4K
Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
5.4K
Antiepileptic Drugs: Calcium Channel Blockers
315
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
315
Antiepileptic Drugs: Sodium Channel Blockers
415
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
415
Voltage-gated Ion Channels
8.0K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
8.0K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K


